The QualityStocks Daily Monday, May 13th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (MOST) +60.54%

StockMarketWatch (TVIX) +27.85%

Schaeffer's (UVXY) +21.43%

The QualityStocks Daily Stock List

Teranga Gold Corporation (TGCDF)

Mining Stock Valuator, TipRanks, 24hourgold, Short Squeeze, Invest Tribune, Wallet Investor, Market Screener, Dividend Investor, Street Insider, Equity Clock, Stockhouse, and InvestorsHub reported earlier on Teranga Gold Corporation (TGCDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Teranga Gold Corporation engages in the exploration, development, production, and sale of gold in West Africa. The Company is a multi-jurisdictional West African gold company also centered on the exploration of roughly 6,400 km2 of land situated on prospective gold belts. Its projects include Sabodala, Wahgnion, and Golden Hill. OTCQX-listed, Teranga Gold has its corporate office in Toronto, Ontario.

The Sabodala gold mine is located in the Republic of Senegal. The Wahgnion gold project is located in Burkina Faso. The 100 percent owned Golden Hill project is located in southwestern Burkina Faso on the Houndé belt. Golden Hill includes three exploration permits encompassing an area of roughly 468 square kilometers, In addition, Teranga Gold develops and explores various projects in Burkina Faso, Côte d'Ivoire, as well as Senegal.

Earlier this month, Teranga Gold reported financial and operating results for the three months ended March 31, 2019. The Company also provided an update on the development progress of its second mine, Wahgnion. For Q1 2019 in comparison to Q1 2018, Teranga had record quarterly gold production of 71,946 ounces. This represents an increase of 12 percent.

Per ounce cost metrics decreased by up to 9 percent. Moreover, they were below the respective full-year guidance ranges, including all-in sustaining costs - AISC (excluding non-cash inventory movements and amortized advanced royalty costs) of $806 per ounce.

Net Income Attributable to Shareholders decreased to a loss of $2.7 million, or $0.03 per share. Adjusted Net Income Attributable to Shareholders was $2.2 million, or $0.2 per share. Net Income and Adjusted Net Income were negatively affected by a pending tax assessment for $10 million. The construction schedule for Teranga Gold's second mine, Wahgnion, in southwest Burkina Faso, is on course and entering its final phases.

Since its initial public offering in 2010, Teranga Gold has produced greater than 1.7 million ounces of gold at its Sabodala operation in Senegal. The Company had more than 4.0 million ounces of gold reserves as of June 30, 2018.

Last week, Teranga Gold announced that each of the nine nominee Directors listed in the Management Proxy Circular dated April 3, 2019, were elected as directors of the Company at its Annual General Meeting of Shareholders held in Toronto on May 7, 2019.

Teranga Gold Corporation (TGCDF), closed Monday's trading session at $2.55, up 13.54%, on 17,870 volume with 21 trades. The average volume for the last 3 months is 27,957 and the stock's 52-week low/high is $2.226/$4.325.


MobileSmith, Inc. (MOST)

Market Exclusive, Zacks, YCharts, MarketWatch, Simply Wall St, Market Screener, Marketbeat, Wallet Investor, Last10k, InvestorsHub, Wallmine, GuruFocus, Business Insider, Capital Cube, Corporate Information, Stockopedia, Stockwatch, Proactive Investors, Trading View, 4-Traders, Dividend Investor, and Stockhouse reported earlier on MobileSmith, Inc. (MOST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MobileSmith, Inc. is a leader in the digital health and mobile development sector. It provides operational improvement member-facing mobile application (app) services to the healthcare industry in the U.S. The Company helps its clients improve health outcomes, patient satisfaction and grow profit margins using its toolbox of proven mobile app technologies. OTCQB-listed, MobileSmith has its corporate office in Raleigh, North Carolina.

The Company is changing healthcare one app at a time through targeting the evident inefficiencies in the U.S. healthcare delivery model. Greater than 60 healthcare systems and organizations are partnering with MobileSmith Health to deliver a new healthcare experience and embrace the impact of technology as an agent of change.

Fundamentally, MobileSmith is helping its clients meet their healthcare consumers where they are, on their mobile devices, to expand the reach of providers to modify behavior with apps that remind, educate, track, and also engage the patients that use them.

MobileSmith is focusing on select patient segments that struggle with areas such as medication adherence, discharge instruction compliance, and health literacy, and provide new unique digital patient experiences including indoor navigation and clinic "check-ins", which directly improve critical patient satisfaction.

Via the use of MobileSmith Health Blueprints, hospitals and other healthcare organizations can customize their apps based on specific feature sets, workflow, branding, protocol, procedure and service line. This is while launching in as little as 90 days. MobileSmith's latest Blueprints 3.0 offerings provide expanded mobile capabilities across the Company's main applications: In-Network Apps, Perioperative Apps, and Patient Acquisition apps. Additional Blueprint 3.0 features include key mobile-specific functionality such as self-triage, remote check-in, wayfinding and EMR interoperability.

Last month, MobileSmith Health announced a collaboration with Kaweah Delta Medical Center on the release of a surgery app. This app provides patients and caregivers with timed notifications, digital trackers and interactive resources about what to expect before, during and after surgery. The Kaweah Delta Surgery App was developed using MobileSmith Health's signature Blueprints.

This month, MobileSmith Health announced the launch of Perioperative Blueprints 4.0. The expanded app Blueprints include new functionality, which tailors the patient experience pre- and post-op with the introduction of "Peri," which offers AI-based (Artificial Intelligence) interactions that elevates patient literacy with conversational interfaces, video, as well as images. EMR integration and new adherence tracking dashboards permit providers to readily assess risk factors for complications, cancellations or readmissions.

MobileSmith, Inc. (MOST), closed Monday's trading session at $1.6375, up 60.54%, on 832 volume with 8 trades. The average volume for the last 3 months is 568 and the stock's 52-week low/high is $0.75/$2.51.


CCUR Holdings, Inc. (CCUR)

Stock Twits, Stocksholm, Pitch Book, Seeking Alpha, Insider Tracking, 4-Traders, YCharts, Value Walk, TipRanks, Zacks, MarketWatch, Vintage Value Investing, Simply Wall St, Market Screener, The Street, Stockwatch, Last10k, InvestorsHub, Equity Clock, and Stockhouse reported previously on CCUR Holdings, Inc. (CCUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CCUR Holdings, Inc., formerly known as Concurrent Computer Corporation, changed its corporate name in January of 2018 following the sale of its former Real-Time business to Battery Ventures in May of 2017 and Content Delivery & Storage business in December of 2017. CCUR Holdings is now pursuing business opportunities to maximize the value of its assets through evaluation of additional operating businesses or assets for acquisition, continued development of its current real estate operations via its subsidiary Recur Holdings LLC, and continued development of its MCA business operations by way of its subsidiary LM Capital Solutions, LLC (LMCS). CCUR Holdings is based in Duluth, Georgia.

The Company's assets include its real estate operations (operated via subsidiary Recur Holdings), cash, securities held, receivables from the sale of its operating businesses held in escrow, taxes receivable, and tax assets attributable to its Net Operating Losses.

CCUR Holdings recently announced that through its newly formed subsidiary, LM Capital Solutions, LLC (LMCS), it closed on a Purchase Agreement to acquire the operating assets of LuxeMark Capital, LLC. LuxeMark operates through its syndication network to facilitate merchant cash advance (MCA) funding through connecting a network of MCA originators with syndicate participants who provide those originators with more capital by purchasing participation interests in funded MCAs. In addition, LuxeMark uses its expertise in the MCA industry to provide servicing and other administrative services to its syndicate network.

Last week, CCUR Holdings reported Net Income for the third fiscal quarter of 2019 of $1,411,000, or $0.16 per share. This represents an improvement from the Net Loss of $1,093,000, or $0.11 a share for the year-ago comparable period. Revenue for the quarter almost tripled on a sequential basis to $1,074,000 with Merchant Cash Advance (MCA) Income increasing to $825,000 and Interest Income on Loans growing to $249,000. Other Interest, Dividend and Investment Income for the period totaled $1,557,000.

Mr. Wayne Barr, President and Chief Executive Officer of CCUR Holdings, said, "By generating net income, as well as positive operating cash flow, our fiscal third quarter results begin to reflect the potential returns we believe CCUR Holdings is capable of generating for our stockholders. Our subsidiary LM Capital Solutions completed the transaction with LuxeMark Capital mid-quarter and we have completed the integration of this investment in the MCA financing space into CCUR's operations. We also grew revenue from our Recur Holdings real estate operations during the quarter and continue to explore additional real estate focused opportunities."

CCUR Holdings, Inc. (CCUR), closed Monday's trading session at $3.43, down 1.15%, on 10,934 volume with 18 trades. The average volume for the last 3 months is 5,342 and the stock's 52-week low/high is $3.00/$5.40.


Grupo Financiero Banorte, S.A.B. de C.V. (GBOOF)

Talkmarkets, NewsTakers, Trading View, Wallet Investor, Marketbeat, GuruFocus, Capital Cube, Market Screener, Investors Hangout, OTC Markets, Financial Content, Equities, Stockhouse, Wallmine, MarketWatch, and YCharts reported earlier on Grupo Financiero Banorte, S.A.B. de C.V. (GBOOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Grupo Financiero Banorte, S.A.B. de C.V., by way of its subsidiaries, provides banking and financial products and services in Mexico. It operates through a network of roughly 1,148 branches, 7,911 ATMs, 26,131 correspondents, and 165,441 point of sale terminals. Grupo Financiero Banorte's shares trade on the OTC Markets Group's OTCQX. The Company is headquartered in Santa Fe, Mexico.

Grupo Financiero Banorte is the second largest financial group in Mexico. Moreover, the Company has the greatest business diversification in the marketplace.

Grupo Financiero Banorte operates under a universal banking model. In addition, it offers a broad array of products and services by way of its brokerage firm, pension and insurance companies, Afore XXI Banorte, investment funds, and leasing and factoring companies and a storage company.

The Company is the number one provider of loans to governments. It is also the second largest bank in mortgage loans. The retirement fund manager Afore XXI Banorte is the largest in the nation in managed resources. Moreover, Grupo Financiero Banorte is the only commercial bank, among the six largest institutions, that is managed by a Mexican Management team.

Grupo Financiero Banorte offers deposits that include demand deposits, term deposits, money market accounts, and investment funds. It also offers credit products consisting of credit cards, car loans, payroll loans, and mortgages.

Furthermore, the Company provides services for banking, brokerage, warehousing, leasing, and factoring services. It also provides Internet banking, mobile banking, as well as call center services. Additionally, Grupo Financiero Banorte engages in long term savings, insurance, and global banking businesses.

The Company was founded in 1899 as Banco Mercantil de Monterrey Foundation. In 1993, Grupo Financiero Banorte was born. In 2017, Indexamericas recognized the Company as a leader in Sustainability. Also in 2017, Banorte was recognized within the Brand Finance Banking 500 ranking. In 2018, The Banker magazine recognized Grupo Financiero Banorte as the best Bank of Mexico.

Grupo Financiero Banorte, S.A.B. de C.V. (GBOOF), closed Monday's trading session at $5.8117, up 3.41%, on 369 volume with 1 trade. The average volume for the last 3 months is 23,431 and the stock's 52-week low/high is $4.02/$7.25.


Humanigen, Inc. (HGEN)

NetworkNewsWire, TipRanks, Street Insider, GlobeNewswire, InvestorsHub, Proactive Investors, Stockhouse, StreetWise Reports, 4-Traders, Trading View, Investors Hangout, Whale Wisdom, Insider Financial, Morningstar, Equity Clock, Barchart, Proactive Investors, Stockopedia, and Marketbeat reported previously on Humanigen, Inc. (HGEN), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

A biopharmaceutical enterprise, Humanigen, Inc. is developing its Humaneered® proprietary monoclonal antibodies to address critical unmet needs in today's most advanced cancer therapies. The Company is developing its portfolio of Humaneered® monoclonal antibodies centered on CAR-T optimization and immuno-oncology. Humaneering is a patented proprietary technology for converting suboptimal antibodies into human antibodies suitable for chronic therapies, in part, due to low immunogenicity.

Humanigen is headquartered in Burlingame, California. The Company previously went by the name KaloBios Pharmaceuticals, Inc. It changed its name to Humanigen, Inc. in August of 2017. The Company's shares trade on the OTC Markets Group's OTCQB.

Derived from Humanigen's Humaneered® platform, lenzilumab and ifabotuzumab, and HGEN005 are monoclonal antibodies with first-in-class mechanisms.  Lenzilumab targets GM-CSF. It is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, and also a potential treatment for hematologic cancers.

Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is being explored as a potential treatment for glioblastoma multiforme (GBM) and a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, and also a backbone for a novel CAR-T construct, and a bispecific antibody platform.

HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.

Recently, Humanigen announced that on March 21, 2019, data from the study entitled "GM-CSF Blockade during Chimeric Antigen Receptor T-cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and may Enhance CART Effector Function" were presented at the 2019 NCCN Annual Conference: Improving the Quality, Effectiveness, & Efficiency of Cancer Care™ in Orlando, Florida. It was presented in the oral plenary session centered on new immunotherapy strategies for improving outcomes.

The study was conducted using lenzilumab, Humanigen's proprietary Humaneered® anti-GM-CSF monoclonal antibody. The study was recently featured on the front cover of the February 14, 2019 edition of 'blood'®, the official journal of the American Society of Hematology, available online at

Dr. Cameron Durrant, Humanigen Chief Executive Officer, said, "This study identifies GM-CSF as a key trigger in the inflammatory cascade resulting in CRS and NI and demonstrates the ability to break the efficacy toxicity linkage by targeting the key cytokine in the inflammatory cascade. These results suggest that GM-CSF neutralization would improve the efficacy and toxicity profile of current CAR-T therapies and opens the possibility for other combinations with agents that might further improve efficacy but would too toxic if used in the absence of GM-CSF neutralization."

Humanigen, Inc. (HGEN), closed Monday's trading session at $1.15, up 9.52%, on 525 volume with 4 trades. The average volume for the last 3 months is 12,059 and the stock's 52-week low/high is $0.27/$1.54.


Ionix Technology, Inc. (IINX)

Wallet Investor, YCharts, Current Charts, Barchart, The Street, Morningstar, Small Cap Exclusive, Market Exclusive, Wallmine, OTC Markets, Simply Wall St, Stockhouse, Financial Content, MarketWatch, Stockopedia, Last10k, Dividend Investor and Open Insider reported earlier on Ionix Technology, Inc. (IINX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. The Company is focusing on becoming the business aggregator that mainly promotes photoelectric display, smart energy and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. OTCQB-listed, the Company formerly went by the name Cambridge Projects, Inc. It changed its corporate name to Ionix Technology, Inc. in February 2016.

Ionix Technology has four operating subsidiaries. One is Changchun Fangguan Photoelectric Display Technology Co., Ltd. It specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd. It specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Subsidiary Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices. In addition, subsidiary Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking.

Currently, the Company has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases. This is to capture the market share of OLED high technology.

In January 2019, Ionix Technology announced that it entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd. Changchun Fangguan is a leading manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix Technology acquired control of Changchun Fangguan.

Last month, Ionix Technology announced that its subsidiary Changchun Fangguan Electronics Technology Co., Ltd. completed a capital increase of USD 5.92 Million to invest in its OLED flexible screen business. In December 2018, Ionix acquired 95.14 percent control of Changchun Fangguan and became an aggregator in the photoelectric display and smart energy fields in China. This has also laid a strong foundation for its prospective future development and technology innovation.

Mr. Yubao Liu, Ionix Technology Chief Executive Officer, stated, "This capital increase not only improves the equity interest of shareholders and investors, it also doubled the net assets of Changchun Fangguan, dramatically increased the shareholders' equity and enhanced the confidence and determination of the team. In addition, we hope that it will draw the attention of investors to IINX, and interest them to invest in IINX to promote our rapid and sustainable development in the fields of photoelectric displays and smart energy."


Ionix Technology, Inc. (IINX), closed Monday's trading session at $1.72, even for the day, on 100 volume. The average volume for the last 3 months is 2,354 and the stock's 52-week low/high is $1.20/$2.75.


Uniroyal Global Engineered Products, Inc. (UNIR)

NetworkNewsWire, StockPulse, Zacks, Simply Wall St, Infront Analytics, Wallet Investor, Stockhouse, Proactive Investors, Capital Network, Proactive Investors, Market Screener, and OTC Markets reported previously on Uniroyal Global Engineered Products, Inc. (UNIR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc. (UNIR) is a worldwide provider of vinyl coated fabrics products that have diverse high performance characteristics and capabilities. These products are manufactured by the Company's subsidiaries Uniroyal Engineered Products, LLC and Uniroyal Global Limited. UNIR is a foremost manufacturer of vinyl-coated fabrics, which are durable, stain resistant, cost-effective alternatives to leather, cloth and other synthetic fabric coverings. OTCQB-listed, UNIR is headquartered in Sarasota, Florida.

The Company's coated fabrics products are frequently used in applications that require rigorous performance characteristics. These include automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities and athletic equipment. UNIR's main brands names include Naugahyde®, BeautyGard®, Flameblocker™, Spirit Millennium®, Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

UNIR's products for the automotive industry are chiefly used in seating, door panels, head and arm rests, security shades and trim components, including instrument panels, door casings, seating, gear lever and steering column gaiters, headliners and load space covers. Moreover, non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pram and nursery, movie screen and decorative surface applications.

In 2018, UNIR's revenue was derived 66.2 percent from the automotive industry. Roughly 33.8 percent was derived from the recreational, industrial, indoor and outdoor furnishings, hospitality and healthcare markets.

UNIR has opened a new Detroit, Michigan area office dedicated to the North American automotive market. This new office features a design studio along with a sales team committed to serving existing original equipment manufacturer (OEM) customers and new automotive clients. The office is in Farmington Hills. It joins other UNIR offices in Stoughton, Wisconsin; Sarasota, Florida; Earby, Lancashire, UK; and Shanghai, China.

Last week, UNIR reported its financial results for the three months ended March 31, 2019. Net Sales for the three months ended March 31, 2019 decreased $1,035,827 or 3.9 percent to $25,393,860 from $26,429,687 recorded in the year prior. Excluding the negative currency effect of the exchange rates, Total Revenue would have only decreased by about $33,000 or 0.1 percent.

Operating Income for the three months ended March 31, 2019 was $880,397, in comparison to $898,200 in the prior year. This represents a decline of $17,803 or 2.0 percent. The main reasons for the drop were lower sales and a contraction in Gross Profit margins to 17.0 percent this year in comparison to 17.5 percent in the prior year.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Monday's trading session at $1.25, up 25.00%, on 1,519 volume with 4 trades. The average volume for the last 3 months is 1,368 and the stock's 52-week low/high is $1.00/$2.00.


Flux Power Holdings, Inc. (FLUX)

StreetWise Reports, MarketWatch, Stockhouse, Business Wire, Seeking Alpha, GlobeNewswire, The Street, Barchart, InvestorsHub, Equity Clock, Wallet Investor, YCharts, Zacks, Market Screener, and Proactive Investors reported previously on Flux Power Holdings, Inc. (FLUX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications, including electric forklifts and airport ground support equipment. The Company's solutions use its proprietary battery management system and in-house engineering and product design. Flux Power sells mainly to lift equipment OEM's (Original Equipment Manufacturers), their dealers and battery distributors. Formed in 2009 and OTCQB-listed, Flux Power Holdings has its head office in Vista, California.

Flux Power initially concentrated on electric automobiles. It turned to industrial equipment in 2013. The Company develops advanced lithium-ion batteries for industrial uses, including its first-ever UL 2271 Listed lithium-ion "LiFT Pack" forklift batteries. Flux Power batteries deliver improved performance, extended cycle life, and lower total cost of ownership than legacy lead-acid solutions. The Company's current products include advanced battery packs for motive power in the lift equipment and airport ground support markets.

Flux Power's Class 3 Walkie LiFT Pack was introduced in 2014. It is the only pack tested and approved by major OEM's: Toyota, Raymond, and Crown Equipment. UL approval was attained in 2016: the only UL Listed pack in the forklift industry for multiple forklift brands. The Company has its Class 3 Walkie Pallet Jack; its Class 1 Counter Balance; and also its Class 3 End Rider, Class 2 Narrow Aisle, and Airport GSE equipment.

The Company also has its Flux Packs: Cells and Patented Electronics. This is a battery for Class 3 forklifts -- "walkie" pallet jacks. The Flux modular design is based on this "Walkie" pallet pack. Software and firmware are located in BCM (Battery Control Module) and BMSM (Battery Management System Modules).

Flux Lithium-Ion "LiFT Packs" run longer shifts and offer 30-50 percent electricity savings. They support multiple shifts (that is fewer batteries). Moreover, they have a 5 Year Warranty (walkies).

Recently, Flux Power Holdings announced that it was selected by a major international forklift manufacturer to supply lithium-ion batteries for the forklift manufacturer's walkie pallet jack forklift line, pursuant to a private label OEM relationship. Flux Power is providing a custom-designed lithium-ion energy storage solution for the forklift manufacturer's walkie pallet jack lift trucks.

Flux Power Holdings, Inc. (FLUX), closed Monday's trading session at $1.14, down 0.87%, on 8,602 volume with 20 trades. The average volume for the last 3 months is 4,180 and the stock's 52-week low/high is $0.49/$3.35.


Cobalt 27 Capital Corp. (CBLLF)

Hottest Stock Picks, Energy and Capital, Streetwise Reports, Barchart, MarketWatch, Proactive Investors, Morningstar, Tip Ranks, Dividend Investor, Market Screener, InvestorsHub, Seeking Alpha, Junior Mining Network, Metals News, GuruFocus, The Street, and Wallet Investor reported on Cobalt 27 Capital Corp. (CBLLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Cobalt 27 Capital Corp. is a foremost battery metals streaming company listed on the OTC Markets' OTCQX. The Company offers exposure to metals essential to key technologies of the electric vehicle and energy storage markets. Cobalt 27 Capital's intention is to continue investing in an electric metals-focused portfolio of streams, royalties and direct interests in mineral properties containing cobalt. This is while potentially adding to its cobalt physical holdings when opportunities arise. Cobalt 27 Capital has its corporate headquarters in Toronto, Ontario.

The Company's strategy of holding physical cobalt, streams and royalties will avoid the operational, environmental, closure and capital risks associated with typical mining companies. Likewise, Cobalt 27 Capital will not be exposed to any operational risks carried by automakers and battery producers. Through holding physical cobalt and electric metals focused streams and royalties, it will be able to participate in price appreciation while minimizing exposure to risks.

Cobalt 27 owns physical cobalt and a 32.6 percent Cobalt Stream on Vale's world-class Voisey's Bay mine,‎ beginning in 2021. The Company is undertaking a friendly acquisition of Highlands Pacific that is expected to add increased attributable nickel and cobalt production from the long-life, world-class Ramu Mine.

In addition, Cobalt 27 manages a portfolio of 11 royalties. The Company's acquisition strategy is to fully exploit present market opportunities to invest in streams and royalties and deliver growth as the leading electric metals investment vehicle.

Recently, Cobalt 27 Capital provided a status update on its earlier announced acquisition of Highlands Pacific Limited, through a definitive scheme implementation agreement, whereby Cobalt 27 proposes to acquire all of the issued ordinary shares of Highlands that it does not own by means of a scheme of arrangement under Part XVI of the PNG Companies Act in Papua New Guinea (PNG).

Highlands is a mining and exploration company and its main assets include an 8.56 percent interest in the producing Ramu mine and a 20 percent interest in the Frieda River Copper-Gold Project, both in PNG. Additionally, Highlands holds the Star Mountains Copper Gold exploration project in PNG and has exploration tenements on Normanby Island (Sewa Bay).

On March 12, 2019, Highlands filed the Independent Expert's Report concluding the Scheme is fair and reasonable, and consequently in the best interests of Highlands' shareholders. The National Court of PNG ordered a meeting for Highlands' shareholders to vote on the Scheme that has been set for April 30, 2019.

Cobalt 27 is now Highlands' single largest shareholder, having increased its equity interest from 13 percent to roughly 19.99 percent during Q1 of 2019. Highlands' 45-day period to approach other parties for better offers on its project interests ended February 16, 2019. Upon close of the proposed Highlands acquisition, Cobalt 27 will gain an 8.56 percent interest in the producing Ramu nickel-cobalt mine.

Cobalt 27 Capital Corp. (CBLLF), closed Monday's trading session at $2.96, up 0.37%, on 1,567 volume with 9 trades. The average volume for the last 3 months is 22,451 and the stock's 52-week low/high is $2.45/$9.607.


Metalla Royalty & Streaming Ltd. (MTAFF)

Live Trading News, Insider Financial, OTC Markets, YCharts, Stockwatch, Proactive Investors, Junior Mining Network, GuruFocus, The Street, Market Screener, Nasdaq, InvestorsHub, Investorx, Stockhouse, King World News, Uptick Newswire, Mining Feeds, and Dividend Investor reported earlier on Metalla Royalty & Streaming Ltd. (MTAFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Metalla Royalty & Streaming Ltd. established to provide shareholders with leveraged precious metal exposure through acquiring royalties and streams. The Company has a strong pipeline of transactions with favorable rates of return. It is working to accumulate a varied portfolio of royalties and streams with attractive returns. The Company previously went by the name Excalibur Resources Ltd. It changed its corporate name to Metalla Royalty & Streaming Ltd. in December of 2016. Metalla Royalty & Streaming is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets' OTCQX.

Metalla's Streams and Royalties include the Endeavor Silver Stream and the NLGM Silver Stream. In addition, they include the Joaquin Royalty; the Zaruma Royalty; the Hoyle Pond Extension Royalty; the West Timmins Extension Royalty; and the DeSantis Mine Royalty, as well as an assortment of other royalties.

Metalla Royalty & Streaming announced in May of 2018 that it acquired a 2 percent Net Smelter Return (NSR) royalty on the Akasaba West Property from Alexandria Minerals Corporation pursuant to a royalty purchase and sale agreement dated May 11, 2018. With the Agreement, Metalla and Alexandria Minerals entered into an assignment and assumption agreement. The Royalty was transferred from Alexandria Minerals to Metalla Royalty & Streaming.

The Akasaba West Property is a gold-copper deposit in the Bourlamaque and Louvicourt Townships, Val d'Or, Quebec. The Akasaba West Property is owned and operated by Agnico Eagle Mines Limited. The Royalty was acquired for a total purchase price of $250,000 in cash.

Metalla Royalty & Streaming announced this past December that, further to its news release dated December 11, 2018, it completed its acquisition of the 1.5 percent net smelter return (NSR) royalty on the Cap-Oeste Sur East (COSE) property in the province of Santa Cruz, Argentina from Patagonia Gold S.A. (Seller). The Royalty was acquired pursuant to a royalty purchase agreement dated December 7, 2018 under which a wholly-owned Argentinean subsidiary of Metalla (Metalla Argentina) and the Seller entered into an assignment and assumption agreement for the purpose of transferring the Royalty from the Seller to Metalla Argentina.

Recently, Metalla Royalty & Streaming announced that it entered into a purchase and sale agreement to acquire from a third party a 1.0 percent NSR royalty on Atlantic Gold Corporation's Fifteen Mile Stream project for $4,000,000. The Royalty is in connection with two claims formally held by the Seller that encompasses the Egerton-Maclean, Hudson, 149 East Zone, and most of the Plenty deposit that collectively comprise the Fifteen Mile Stream project (FMS Project) in the Province of Nova Scotia. The Royalty covers all products mined or otherwise recovered from the Project.

Metalla Royalty & Streaming Ltd. (MTAFF), closed Monday's trading session at $0.8279, up 7.06%, on 292,446 volume with 108 trades. The average volume for the last 3 months is 176,059 and the stock's 52-week low/high is $0.479/$1.075.


MGT Capital Investments, Inc. (MGTI)

MicroCap Daily, OTC Markets, Barchart, Equity Clock, TipRanks, Zacks, Insider Tracking, Stockhouse, Simply Wall St, MarketWatch, GuruFocus, Insider Financial, Finance Registrar, InvestorsHub, The Street, and Seeking Alpha reported earlier on MGT Capital Investments, Inc. (MGTI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

MGT Capital Investments, Inc. ranks as one of the largest U.S.-based Bitcoin miners. The Company has its facility in Washington State. In addition, it has a facility in northern Sweden. MGT also continues to focus on an expansion model to secure low cost power and grow its crypto assets materially. MGT Capital Investments is headquartered in Durham, North Carolina. The Company's shares trade on the OTC Markets Group's OTCQB.

MGT Capital Investments started Bitcoin Mining in Washington State in September 2016. These facilities are still presently mining. In Q1 2018, MGT commenced a transition of its mining assets from Washington State to Northern Sweden.

MGT owns and operates approximately 6,000 Bitmain S9 miners, and 50 GPU-based Ethereum mining rigs. The Company signed a Letter of Intent (LOI) with Bitmain Technologies Limited. This is to establish a joint venture (JV), which will focus on opportunities in the Bitcoin space in North America. The proposed JV between MGT Capital Investments and Bitmain Technologies will lead to the development of a state-of-the-art Bitcoin mining pool.

The Company also entered into a consulting agreement with Future Tense Secure Systems, Inc. Future Tense is a technology incubator with investments in other applications requiring privacy, including chat and file sharing.

MGT Capital Investments has completed the move of its Swedish operations to locations in Colorado and Ohio. The Company has stated that when Bitcoin mining economics allow for profitable operation, it would restart mining.  All but 600 miners are now racked and plugged in, and ready to begin operation. MGT has entered into a Letter of Intent (LOI) with Standard Power of Ohio expected to significantly improve Bitcoin mining economics for MGT.

The proposed arrangement foresees a management agreement where MGT Capital Investments provides up to 2,400 miners and Standard Power provides the hosting facility and infrastructure. Subsequent to paying net electricity costs and onsite labor, the two companies will split the operating profit.

MGT Capital Investments, Inc. (MGTI), closed Monday's trading session at $0.0763, up 10.45%, on 11,989,949 volume with 689 trades. The average volume for the last 3 months is 4,335,486 and the stock's 52-week low/high is $0.028/$1.409.


Acacia Diversified Holdings, Inc. (ACCA)

Proactive Investors, MarketWatch, Zacks, Seeking Alpha, YCharts, Daily Marijuana Observer, Wallet Investor, PR Newswire, Corporate Information, 4-Traders,, Real Pennies, InvestorsHub, GlobeNewswire, Morningstar, Insider Financial, and Simply Wall St reported earlier on Acacia Diversified Holdings, Inc. (ACCA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Acacia Diversified Holdings, Inc. is an emerging cannabis business headquartered in Clearwater, Florida. The Company's wholly-owned subsidiaries are MariJ Pharmaceuticals, Inc. (MariJ) and Eufloria Medical of Tennessee, Inc. (Eufloria). Via these, Acacia concentrates on the growing and distribution of new and proprietary medicinal hemp products for patients, USDA certified organic mobile processing and handling solutions for its customers, and technology solutions for the expanding physician market. Acacia Diversified Holdings lists on the OTCQB.

Moreover, Dahlia's Botanicals is another part of the Acacia portfolio. A portion of sales from its U.S.D.A Certified Organic Hemp product goes to the Cannamoms organization.

MariJ Pharmaceuticals is the exclusive organic extraction company. MariJ's focus is on the extraction and processing of very high quality, high-CBD/low-THC content medical grade cannabis oils from medical cannabis plants. MariJ specializes in organic strains of the plant. This sets itself apart from the general producers of non-organic products.

Additionally, MariJ Pharmaceuticals has the technical expertise and capability to process and formulate the oils and to use them in its compounding operations. Furthermore, it has its proprietary Geotraking Technology. This technology is totally compliant with the Health Insurance Portability and Accountability standard (HIPAA), using its "plant to patient" solution.

Acacia Diversified Holdings has a 14-acre farm with 32,000 square feet of indoor grow area in southern Tennessee. It acquired an option to purchase the farm, upon favorable terms, which option, Eufloria Medical of Tennessee intends to exercise. Acacia Diversified Holdings also acquired MEDAHUB Operations Group, Inc. and MEDAHUB, Inc. These are technology companies complete with a current compounding pharmacy license in the State of Florida.

Recently, Acacia Diversified Holdings announced its partnership with Tennessee State University (TSU) for potentially pioneering hemp research. Eufloria Medical of Tennessee will be manufacturing material for the university study. Eufloria is a vertically-integrated hemp operation, an innovative model of operations in Tennessee.

The research partnership aims to create a safe and chemical-free vehicle to obtain the health benefits of the whole-hemp plant into almost anything from food and beverages to topical creams. The TSU research could produce unique ways to obtain whole plant extract.

Acacia Diversified Holdings, Inc. (ACCA), closed Monday's trading session at $0.0465, up 3.33%, on 750 volume with 3 trades. The average volume for the last 3 months is 68,952 and the stock's 52-week low/high is $0.0308/$0.408.


OceanaGold Corporation (OCANF)

SimVest, Dividend Investor, MarketWatch, Seeking Alpha, InvestorsHub, Stockhouse, Wallet Investor, YCharts, Barchart, OTC Markets, Morningstar, Trading View, Stockscores, Tip Ranks, InvestorsHub, Stockwatch, Self Directed Investor, SmallCap Network, Insider Monkey, The Street, GuruFocus, and Ticker Report reported earlier on OceanaGold Corporation (OCANF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OceanaGold Corporation is a mid-tier, high-margin, multinational gold producer. The Company has assets in the United States, the Philippines, and New Zealand. Its flagship asset is the Didipio gold-copper mine on the island of Luzon in the Philippines. In 2018, the Didipio underground progressed to plan. OceanaGold has its head office in Melbourne, Australia. The Company's Americas Corporate Office is in Denver, Colorado. OceanaGold lists on the OTC Markets.

In the United States, OceanaGold operates the Haile Gold Mine. This is a top-tier, long-life, high-margin asset in South Carolina. In 2016, OceanaGold completed the construction of the Haile Gold Mine. In 2017, the Company achieved commercial production at Haile. In 2018, the Haile process plant expansion was taking place.

On the South Island of New Zealand, OceanaGold operates the largest gold mine in the nation at the Macraes Goldfield, which comprises a series of open pit mines and the Frasers underground mine. On the North Island of New Zealand, OceanaGold operates the high-grade Waihi Gold Mine. It has commenced permitting of a 10-year mine life extension at Waihi.

OceanaGold also has a substantial pipeline of organic growth and exploration opportunities in the Americas and Asia-Pacific regions. Last year, it processed high grade ore from Coronation North. In addition, the Company has its Argentina Joint Ventures (JVs). OceanaGold has the potential to earn-in up to 75 percent on each project in this fertile gold region.

OceanaGold announced recently, an update on exploration activities at its Haile Gold Mine in South Carolina. A selection of significant drill results include 68.3 meters @ 3.57 g/t Au at the Snake expansion; 24.4 meters @ 8.19 g/t Au at Snake; 33.4 meters @ 4.33 g/t Au at Ledbetter; and 15.1 meters @ 9.26 g/t Au at Ledbetter. Highlights also include 24.5 meters @ 3.21 g/t Au at Ledbetter and 20.1 meters @ 7.23 g/t Au at Red Hill.

Recently, OceanaGold announced an updated Mineral Resource estimate for the Martha Underground Project and recent exploration results highlighting continued high-grade gold intersections at its Waihi Gold Mine in New Zealand. Highlights include increasing the total Indicated Resource by 136 percent to 331,000 ounces of gold and increasing the total Inferred Resource by 97 percent to 667,000 ounces of gold.

OceanaGold Corporation (OCANF), closed Monday's trading session at $2.97, up 4.95%, on 110,132 volume with 86 trades. The average volume for the last 3 months is 66,106 and the stock's 52-week low/high is $2.40/$3.74.


Argentina Lithium & Energy Corp. (PNXLF)

InvestorsHub, Financial Content, The Street, Business Insider, Marketwired, GlobeNewswire, Barchart, Nasdaq, Stockhouse, MarketWatch, Wallet Investor, 4-Traders, Morningstar, and OTC Markets reported earlier on Argentina Lithium & Energy Corp. (PNXLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Argentina Lithium & Energy Corp. focuses on the acquisition and exploration of natural resource properties in Argentina. The Company concentrates on acquiring high quality lithium projects in Argentina and advancing them towards production to meet the growing international demand from the battery sector. A natural resource company and OTCQB-listed, Argentina Lithium & Energy has its corporate office in Vancouver, British Columbia. The Company has its Argentina Exploration Office in Mendoza, Argentina.

Argentina Lithium & Energy has its Antofalla Project. This Project includes greater than14,000 hectares on the Salar de Antofalla in Salta Province, Argentina. This includes a 100 percent interest in roughly 9,000 hectares of mining claims in the north end of the Salar de Antofalla (Staked Properties) and an option agreement to earn a 100 percent interest in three additional properties totaling more than 5,300 hectares (Optioned Properties) positioned adjacent to the Staked Properties.

The Optioned Properties include two granted mine concessions and a third mine application. Terms of the option include cash payments totaling US$3,500,000 over 42 months but limited to only $500,000 in the first 18 months. Moreover, the option includes annual exploration expenditure commitments of $500,000 in year one, followed by $1.5M in year two, $2.0M in year 3, and $3.0M in year 4.

The Company has acquired a 100 percent interest in more than 25,500 hectares covering the Incahuasi Salar and basin in Catamarca province. This salar is within the "Lithium Triangle" of Argentina and Chile. It has characteristics prospective for lithium-rich brines. Initial sampling of near-surface brines returned up to 409mg/L lithium. Geophysical surveying indicates the potential for lithium-rich brines at depth.

Argentina Lithium & Energy is a member of the Grosso Group. The Grosso Group is a resource management group that has pioneered exploration in Argentina since 1993.
At the end of February, Argentina Lithium & Energy announced that Mr. Nick DeMare resigned as a Director the Company. Mr. Nikolaos Cacos, President & Chief Executive Officer of Argentina Lithium & Energy, said, "We want to thank Mr. DeMare for his valuable contributions while serving on the Board." Mr. DeMare has consented to continue serving the Company in an advisory capacity.

Argentina Lithium & Energy Corp. (PNXLF), closed Monday's trading session at $0.047, up 3.52%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 1,408 and the stock's 52-week low/high is $0.033/$0.269.


The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGRMF).

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of government relations expert Cameron Bishop as the Company's Vice President, Public Affairs and Stakeholder Relations (North America).

Organigram Holdings Inc. (TSX.V: OGI) (OTC: OGRMF) is the parent company of Organigram Inc., an original and leading Canadian licensed producer ("LP") of premium, quality cannabis and extract-based products. Founded in 2013 and headquartered in Moncton, New Brunswick, Canada, Organigram is focused on producing the highest-quality indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint. 

Organigram delivers industry-leading yields and maximizes cannabis production at the lowest cultivation cost among other Canadian licensed producers. Organigram's high-tech facilities utilize an efficient, state-of-the-art mechanical room that includes both ethanol and CO2 extraction methods.

The company first began as a medical cannabis provider producing 5,000 kg/year (11,000 lbs) of 100 percent organic cannabis grown in pre-fabricated grow pods. Within two years, Organigram increased production to 36,000 kg/year (70,000 lbs) by utilizing an inventive, indoor 3-tier growing system. The company's pharmaceutical grade, state-of-the-art facility currently houses over 45,000 flowering plants growing at any one time.

Organigram's head office, production facility and research & development program are located on the company's 14-acre campus that houses several buildings and a 40-megawatt substation. Leading the way with a proprietary software system that acts as the nervous system of the entire organization, Organigram's team employs a data-driven decision-making process that ensures efficiency and top yields. Numerous design and automation improvements include an ergonomically friendly grow room design, automatic potting machines and automated packaging lines, and larger propagation rooms with advanced environmental systems.

Organigram's fully funded Phase 4 expansion is underway which, when complete by fall of 2019, will bring production capacity of high-quality premium cannabis to 113,000 kg/year (249,000 lbs). The Company has also invested in Hyasynth, a Montreal-based biotechnology company and leader in the field of cannabinoid science and biosynthesis. Hyasynth has developed a disruptive technology using patented enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation.

Organigram expects to double its workforce within the year to accommodate increasing growth as the facility expands to 480,000 square feet of production space at full buildout. In September 2017, Organigram signed the first ever recreational cannabis supply agreement in Canada with the Province of New Brunswick. Since then, Organigram has signed similar supply agreements with nine out of 10 provinces, has already exported product out of Canada, and is currently working with German medical cannabis provider, Alpha-cannabis, and Serbia-based Eviana Health Corp. (CSE: EHC), a hemp farm and processing facility.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado, with 16 retail locations, for development of commercial scale extraction and product processing, along with derivative product development (edibles, vaporizable products and beverage product mixes). Organigram's partnership with Canada's Smartest Kitchen, a leader in food product development, will expand and develop the Company's edibles R&D program and creation of premium chocolate products. Organigram has also signed a multi-year extraction contract with Valens GroWorks Corp. for Valens to produce extract concentrate for oils and derivative products.

Organigram is well-positioned in the cannabis space with several adult-use recreational product lines. These include:

  • Trailblazer offers a consistent value with a pre-roll, milled format
  • Trailer Park Buds provides niche equity for mainstream users that seek pre-rolls
  • Ankr Organics offers premium, organic pre-roll and oils
  • Edison Cannabis Co. delivers robust, high THC in a whole flower, pre-roll and oil produced from premium sorted flowers
  • Edison Cannabis Co. Reserve offers an ultra-premium, large whole flower that is craft cured and hand trimmed

Experienced Executive Team

  • CEO Gregory Engel has more than 30 years of experience in the pharmaceutical industry with over three years of experience as a CEO for a cannabis company.
  • Jeff Purcell, senior vice president of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods.
  • Tim Emberg, senior vice president of sales and commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and consumer packed good industry.
  • Guillermo Delmonte, president of international operations, brings experience in leading a global cannabis company and worked for 2.5 years as CEO of ICC Labs Inc. in Uruguay.
  • Larry Rogers, vice president of international operations, has held roles for Organigram since 2014 including being a member of the board of directors, chief operating officer and vice president/business development.
  • Paolo DeLuca, chief financial officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities.
  • Ray Gracewood, chief commercial officer, has 15 years of experience in the marketing space and is a previous senior director of sales and marketing for Moosehead Breweries Ltd.
  • Michael Tripp, chief legal officer, worked for private practices at respected business law firms in Moncton and Toronto where he acted on over $3 billion in transactions.

Organigram Holdings Inc. (OTCQX: OGRMF), closed the day's trading session at $6.90, off by 2.51%, on 1,519 volume with 4 trades. The average volume for the last 3 months is 1,368 and the stock's 52-week low/high is $2.97/$7.723.

Recent News


TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) ("TransCanna" or the "Company") is pleased to announce that the Company was featured on BTV video which was broadcast this past weekend on BNN. To view the featured broadcast, click the link below:

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $7.22, up 4.03%, on 218,121 volume with 265 trades. The average volume for the last 3 months is 169,382 and the stock's 52-week low/high is $0.769/$7.789.

Recent News


Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

PLUS Products Inc. (CSE:PLUS) (OTCQB:PLPRF), a cannabis branded product manufacturer dedicated to making cannabis safe and approachable, today announced that co-founder and Chief Executive Officer Jake Heimark, will present at the 3rd Annual Cannacord Genuity Cannabis Conference on May 14, 2019. The conference will be held at the Grand Hyatt in New York, NY.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.55, off by 5.08%, on 51,018 volume with 128 trades. The average volume for the last 3 months is 74,342 and the stock's 52-week low/high is $2.81/$6.01.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TGOD) (TSX: TGOD) (US: TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has entered into an agreement with Mediakos UG haftungsbeschraenkt (Mediakos) to be the exclusive distributor of CannabiGold, its premium hemp CBD brand, for the German pharmacy market. Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.852, off by 4.57%, on 856,862 volume with 1,368 trades. The average volume for the last 3 months is 1,241,121 and the stock's 52-week low/high is $1.607/$7.894.

Recent News


Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its wholly-owned subsidiary, 7ACRES, has obtained Health Canada approval for five additional flowering rooms totalling 50,000 sqft of additional production space at its facility in Kincardine, Ontario. Also today, the company announced release of its financial and operating results for the three and nine months ended March 31, 2019.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.47, off by 4.55%, on 432,564 volume with 573 trades. The average volume for the last 3 months is 604,573 and the stock's 52-week low/high is $0.85/$2.04.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE:FRSX), an innovator in automotive vision systems, announced today that the company will exhibit at TU-Automotive Detroit from June 5-6, 2019, at booth number A35.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.15, off by 5.74%, on 27,091 volume with 63 trades. The average volume for the last 3 months is 45,744 and the stock's 52-week low/high is $1.129/$4.43.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a drug-delivery platform innovator with existing cannabinoid licensing agreements in Canada and the United States, as well as internationally. By out-licensing disruptive delivery technology DehydraTECH, the company has created a strong, revenue-generating business model and a growing patent portfolio.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $0.96, off by 7.69%, on 60,112 volume with 72 trades. The average volume for the last 3 months is 123,270 and the stock's 52-week low/high is $0.75/$2.43.

Recent News


Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

A full-scope, premium cannabis cultivation business, Green Hygienics Holdings Inc. (OTCQB: GRYN) is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company's goal is to provide medical and recreational consumers with the best possible product and experience. NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company's newsroom at

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.7099, off by 1.40%, on 3,635 volume with 9 trades. The average volume for the last 3 months is 26,390 and the stock's 52-week low/high is $0.07/$0.722.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF). released an Interview with Sproutly Canada, Inc. (CSE: SPR) (OTC: SRUTF) CEO, Keith Dolo today. WallStreetReporter discussed the company's Infuz2O technology for cannabis beverages and edibles which offers faster onset/offset times for the "cannabis experience." Topics discussed included: Joint venture with Moosehead Breweries to develop and market cannabis infused beverages in Canada, international expansion opportunities, and products line expansion opportunities which includes edibles.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.5385, off by 1.43%, on 605,301 volume with 204 trades. The average volume for the last 3 months is 766,719 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Innovative Properties Inc. d/b/a Nabis Holdings (CSE: NAB; OTC: INNPF; FRA: 71P) ("Nabis" or the "Company"), is pleased to announce that it, through a wholly-owned subsidiary, has signed a definitive agreement to purchase certain assets from PDT Technologies LLC ("PDT"), including extraction and production equipment and rights to lease its current production facility in Port Townsend, WA. In addition, the Company will purchase the exclusive licensing rights throughout the state of Washington to Chong's Choice brand products, one of the leading and most recognizable brands in the cannabis space.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."


While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.471, off by 0.63%, on 148,349 volume with 107 trades. The average volume for the last 3 months is 202,253 and the stock's 52-week low/high is $0.417/$0.791.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX). Inc. (OTCQB: CIIX), having established itself as a leading financial information website for Chinese-speaking investors in the United States and China, recognized unprecedented opportunities in the U.S. cannabis industry. Seeing that opportunity, CIIX began laying the groundwork to capitalize on the growing demand for cannabidiol (CBD)-based nutrition and health products. In doing so, CIIX became the first Chinese company to sell CBD products in the United States.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.46, off by 6.12%, on 120,548 volume with 62 trades. The average volume for the last 3 months is 66,795 and the stock's 52-week low/high is $0.365/$1.25.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

Global lithium market demand has been making headlines recently as industry leaders and governments shift away from fossil fuels. Most consumers are familiar with rechargeable lithium-ion batteries, which make it possible to power vehicles from renewable sources of energy. It's a topic in which Canadian-based mineral explorer QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is fully immersed, as its team of experts continues to develop a NI 43-101-compliant resource estimate for commercial production of lithium at its Irgon lithium mine project in southeastern Manitoba. Excellent access to well-developed mining infrastructure at the company's wholly owned Irgon lithium mine project offers significant value and aids the company in ramping up the near-term production schedule (

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1488, off by 7.35%, on 31,075 volume with 19 trades. The average volume for the last 3 months is 53,210 and the stock's 52-week low/high is $0.1155/$0.512.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Medical cannabis-focused merchant bank Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) this morning announced the launch of Dr. Klein CBD, a new line of pharma-grade infused CBD nutraceuticals that includes skin topicals and bath products. To view the full press release, visit

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (OTCQB: PNNRF), closed the day's trading session at $0.11, off by 16.03%, on 1,000 volume with 1 trades. The average volume for the last 3 months is 491 and the stock's 52-week low/high is $0.10/$0.505.

Recent News


City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

City View Green Holdings Inc. (CSE: CVGR) (formerly Icon Exploration Inc.) (the "Company" or "CVG") trading through the facilities of the Canadian Securities Exchange ("CSE") under the symbol "CVGR" is pleased to announce that it has received official correspondence from Health Canada that it has no critical concerns with the active City View Green application and that it may move ahead with the build out of its facility located at 49 Easton Road in Brantford.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.


Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $8.83, up 14.23%, on 453,252 volume with 2,331 trades. The average volume for the last 3 months is 285,432 and the stock's 52-week low/high is $3.665/$33.51.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.